Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tramesan"'
Autor:
Jelena Loncar, Barbara Bellich, Alessia Parroni, Massimo Reverberi, Roberto Rizzo, Slaven Zjalić, Paola Cescutti
Publikováno v:
Biomolecules, Vol 11, Iss 2, p 243 (2021)
Food and feed safety are of paramount relevance in everyday life. The awareness that different chemicals, e.g., those largely used in agriculture, could present both environmental problems and health hazards, has led to a large limitation of their us
Externí odkaz:
https://doaj.org/article/fae93d02c9764151a84be875e681e38d
Autor:
Slaven Zjalic, Roberto Rizzo, Alessia Parroni, Massimo Reverberi, Barbara Bellich, Jelena Lončar, Paola Cescutti
Publikováno v:
Biomolecules, Vol 11, Iss 243, p 243 (2021)
Biomolecules
Volume 11
Issue 2
Biomolecules
Volume 11
Issue 2
Food and feed safety are of paramount relevance in everyday life. The awareness that different chemicals, e.g., those largely used in agriculture, could present both environmental problems and health hazards, has led to a large limitation of their us
Tramesan, an eco-friendly approach against Septoria disease complex in wheat Wheat is the most cultivated cereal representing the main source of plant proteins in human food. However, up to 50% of worldwide wheat production may be lost because fungal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e2f4cfca3f9f52f23e654ccdb47ab770
https://www.bib.irb.hr/1179886
https://www.bib.irb.hr/1179886
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paola Cescutti, Alessia Parroni, Maria Rosaria Ricciardi, Agostino Tafuri, Massimo Reverberi, Corrado Fanelli, Roberto Licchetta, Anna Adele Fabbri, Simone Mirabilii, Marzia Scarpari
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2017 (2017)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
Despite improvements that occurred in the last decades in the acute myeloid leukemia (AML) treatment, clinical results are still unsatisfactory. More effective therapies are required, and innovative approaches are ongoing, including the discovery of